Argyle Closes First Tranche of LIFE Offering For C$500,000
aTyr PharmaaTyr Pharma(US:LIFE) Newsfile·2025-10-31 12:21

Group 1 - Argyle Resources Corp. has closed the first tranche of its offering of units at a price of C$0.20 per unit, raising aggregate gross proceeds of C$500,000 [1] - Each unit consists of one common share and one share purchase warrant, with the warrant allowing the purchase of one share at an exercise price of C$0.27 for 24 months [1] - The offering was conducted under the listed issuer financing exemption, meaning the units are not subject to resale restrictions [2] Group 2 - The company paid cash fees of $16,800 and issued 84,000 broker warrants as consideration for finder services, with each broker warrant also exercisable at $0.27 for 24 months [3] - The net proceeds from the offering will be used for legal and accounting expenses, marketing, mineral property exploration, and general working capital [4] Group 3 - Argyle Resources Corp. is a junior mineral exploration company focused on acquiring and evaluating natural resource properties in North America, owning a 100% interest in several silica projects in Québec [6] - The company has options to acquire additional properties, including a rare earth element project in Ontario and a graphite property in Nova Scotia [6] - Argyle is engaged in a research partnership with the National Institute of Scientific Research to conduct exploration programs on its silica projects [6]